Ellison has leased more than 40 acres in Oxford Science Park, which is jointly owned by Singapore’s sovereign wealth fund and ...

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.

New discoveries are showing how genetic variations can affect our health, from disease risks to how we respond to medicines. Understanding the genetics of animals, plants, and microbes helps us see ...

CNW/ - The highly anticipated AI Trends 2026 report from Info-Tech Research Group highlights the five key trends that will ...

Four Americans and a Ukrainian pleaded guilty to helping North Korean operatives secure remote U.S. tech jobs using stolen ...

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter.

A motorcyclist found the infant girl alongside a road in 1983. Forty two years later, DNA technology led to the identification of her parents, but not to charges.

Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios’ potential first-in-class ATR ...

We also have our own internal Cisco LLM. As it uses up-to-date Cisco data—in contrast to external data—its responses are up ...

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer.

There is growing appetite in Silicon Valley for the legally murky and morally frowned upon practice of embryo-editing. This ...